Source | hl7.fhir.uv.ebm#current:null (v5.0.0) |
resourceType | StructureDefinition |
id | m11-section-05 |
canonical | https://hl7.org/fhir/uv/ebm/StructureDefinition/m11-section-05 |
version | 0.1.0 |
status | draft |
publisher | HL7 International - Clinical Decision Support WG |
name | M11Section05 |
date | 2023-08-31T13:08:31+00:00 |
description | Profile of Composition for Evidence Based Medicine IG. The M11Section05 Profile is used for summary of Section 5 Trial Population for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Clinical Electronic Structured Harmonised Protocol (CeSHarP) M11 Technical Specification. |
jurisdictions | uv |
fhirVersion | 5.0.0 |
kind | resource |
abstract | false |
sdTtype | Composition |
derivation | constraint |
base | https://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-report |
Usages | (none) |
Name | Flags | Card. | Type |
Description & Constraints
![]() |
---|---|---|---|---|
![]() ![]() |
EvidenceReport | |||
![]() ![]() ![]() |
1 .. | Slice: Unordered, Open by pattern:text | ||
![]() ![]() ![]() ![]() |
S | 1..1 | ||
![]() ![]() ![]() ![]() ![]() |
1.. | Required Pattern: Section 5 Trial Population | ||
![]() ![]() ![]() |
6 .. | Slice: Unordered, Open by pattern:code | ||
![]() ![]() ![]() ![]() |
S | 1..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.1 Selection of Trial Population | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() ![]() |
Reference (Cohort Definition) | |||
![]() ![]() ![]() ![]() |
S | 1..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.2 Rationale for Trial Population | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() ![]() |
Reference (Cohort Definition) | |||
![]() ![]() ![]() ![]() |
S | 1..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.3 Inclusion Criteria | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() ![]() |
Reference (Cohort Definition) | |||
![]() ![]() ![]() ![]() |
S | 1..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.4 Exclusion Criteria | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() ![]() |
Reference (Cohort Definition) | |||
![]() ![]() ![]() ![]() |
S | 0..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.5 Lifestyle Considerations | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() |
S | 0..1 | ||
![]() ![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() ![]() |
Required Pattern: 5.6 Screen Failures | |||
![]() ![]() ![]() ![]() ![]() |
1.. | |||
![]() |
Produced 08 Sep 2023